Replimune (REPL) Return on Assets (2018 - 2025)

Replimune's (REPL) quarterly Return on Assets came in at 0.01% in Q4 2025, little changed year-on-year from 0.01% in Q4 2024, and down 20.56% quarter-over-quarter from 0.01% in Q3 2025.

Replimune (REPL) Return on Assets (2018 - 2025) Analysis & Trends

Replimune has disclosed Return on Assets across 8 years of filings, most recently posting 0.01% for Q4 2025.

  • Return on Assets for Q4 2025 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
  • Return on Assets came in at 0.01% for Q4 2025 at Replimune, down from 0.01% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.0% in Q1 2021 to a low of 0.01% in Q4 2025.
  • The 5-year median for Return on Assets is 0.0% (2023), against an average of 0.0%.
  • Peak annual rise in Return on Assets reached 0 bps in 2021, while the deepest fall reached 0 bps in 2021.
  • Replimune's Return on Assets stood at 0.0% in 2021, then slipped by 29 bps to 0.0% in 2022, then tumbled by 36 bps to 0.0% in 2023, then retreated by 8 bps to 0.0% in 2024, then sank by 110 bps to 0.01% in 2025.
  • The last three Return on Assets figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.01% (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Alterity Therapeutics 762,369.55 Bn 762,369.51 Bn - -
2 Belite Bio 55,096.00 Bn 55,096.00 Bn - -0.80%
3 Quantum Biopharma 17,755.80 Bn 17,755.79 Bn - -0.01%
4 Legend Biotech 3,486.00 Bn 3,485.71 Bn 242.10 Mn 0.00%
5 Akari Therapeutics 1,737.42 Bn 1,737.41 Bn - -0.01%
6 Evaxion A 1,551.28 Bn 1,551.26 Bn - 0.00%
7 Psyence Biomedical 227.32 Bn 227.31 Bn - 0.00%
8 Vertex Pharmaceuticals 110.84 Bn 103.59 Bn 2.59 Bn 0.00%
9 Abivax 91.71 Bn 91.71 Bn - -0.01%
10 Replimune 780.01 Mn 510.88 Mn - -0.01%

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.01%
Sep 30, 2025 -0.01%
Jun 30, 2025 -0.01%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%
Sep 30, 2024 0.00%
Jun 30, 2024 0.00%
Mar 31, 2024 0.00%
Dec 31, 2023 0.00%
Sep 30, 2023 0.00%
Jun 30, 2023 0.00%
Mar 31, 2023 0.00%
Dec 31, 2022 0.00%
Sep 30, 2022 0.00%
Jun 30, 2022 0.00%
Mar 31, 2022 0.00%
Dec 31, 2021 0.00%
Sep 30, 2021 0.00%
Jun 30, 2021 0.00%
Mar 31, 2021 0.00%